Clinical Trial Update: Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma

View source ↗

Summary

A completed clinical trial evaluated exosome testing as a screening modality for HPV-positive oropharyngeal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Oropharyngeal Cancer | Status: COMPLETED